Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, ranging from 30% in developed countries to 10% in developing countries. Alterations in the production and secretion of adipokines and inflammatory cytokines in NAFLD patients are strongly related to insulin resistance (IR) and other metabolic disorders. Though previous studies have revealed that NAFLD is closely related to the severity of acute pancreatitis (AP), their direct association by clear pathways still needs to be explained.
Moreover, both NAFLD and fatty infiltration of the pancreas are associated with abdominal obesity, dyslipidemia, IR, diabetes mellitus, and hypertension, leading to significant causes of global ill health and economic burden. Thus, to encourage a better understanding of the complications of NAFLD and pancreatic diseases , join us in an exclusive session with Dr.…
